Results 241 to 250 of about 58,634 (303)

Safety of extensive pulsed field ablation for atrial fibrillation in a patient with left ventricular assist device: a case report. [PDF]

Eur Heart J Case Rep
Ouali S, Jebberi Z, Sebki D, Ben Halima M, Mourali MS.   +4 more
europepmc   +1 more source

Hemocompatibility Outcomes After Aspirin Withdrawal in Long‐Term HeartMate 3 Left Ventricular Assist Device Patients on Vitamin K Antagonists

Artificial Organs, EarlyView.
Aspirin discontinuation in long‐term, stable Heart Mate 3 LVAD patients maintained on Vitamin K antagonists did not increase hemocompatibility‐related adverse events. These findings support the safety of simplified antithrombotic therapy and extend randomized evidence for aspirin avoidance to the long‐term management of Heart Mate 3 recipients ...
Melanie Arnreiter, Barbara Karner, Hebe Al Asadi, Christina Abd El‐Malak, Christiane Marko, Daniel Zimpfer, Julia Riebandt, Roxana Moayedifar, Thomas Schlöglhofer   +8 more
wiley   +1 more source

2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias [PDF]

, 2019
Cuculich, Phillip, et al,
core   +1 more source

The Impact of Obesity on Durable Left Ventricular Assist Device Implantation: A Systematic Review and Meta‐Analysis

Artificial Organs, EarlyView.
14 100 LVAD patients across 21 studies were analyzed. Findings indicated that obese LVAD recipients had lower short‐term mortality and higher risk of infection, thrombosis and right heart failure. There was no difference in long‐term survival between obese and non‐obese patients.
Hugh Jacobs, Olivia Frost, Arian Arjomandi Rad, Wing Kiu Chou, Sadeq Al‐Saegh, Alina Zubarevich, Alexander Weymann, Arjang Ruhparwar, Lukman Amanov, Peyman Sardari Nia, Antonios Kourliouros, Thanos Athanasiou   +11 more
wiley   +1 more source

Successful management of biventricular heart failure due to cardiac arrest with isolated left ventricular assist device therapy: a case series. [PDF]

Eur Heart J Case Rep
Komeyama S, Seguchi O, Mochizuki H, Tadokoro N, Watanabe T, Iwai S, Fukushima S, Tsukamoto Y.   +7 more
europepmc   +1 more source

Outcomes in Patients Requiring VENO‐Venous Extracorporeal Membrane Oxygenation After Cardiac Surgery: An Analysis From the PELS‐1 Study

Artificial Organs, EarlyView.
We report an insight from the PELS‐1– a multicentre, international registry focusing on postocardiotomy extracorporeal support use between 2000 and 2020. We focused on 24/2163 (1.1%) patients requiring V‐V ECMO after cardiac surgery. Mortality was high, with 21.7% of patients discharged alive and an overall 1‐year survival probability of 12.5 ...
Pasquale Nardelli, Silvia Mariani, Maria Elena De Piero, Bas C. T. van Bussel, Michele Di Mauro, Ann‐Kristin Schaefer, Diyar Saeed, Matteo Pozzi, Luca Botta, Udo Boeken, Robertas Samalavicius, Karl Bounader, Xiaotong Hou, Jeroen J. H. Bunge, Hergen Buscher, Leonardo Salazar, Bart Meyns, Michael A. Mazzeffi, Marco L. Sacha Matteucci, Sandro Sponga, Kollengode Ramanathan, Claudio Russo, Francesco Formica, Pranya Sakiyalak, Antonio Fiore, Daniele Camboni, Giuseppe Maria Raffa, Rodrigo Diaz, I‐wen Wang, Jae‐Seung Jung, Jan Belohlavek, Vin Pellegrino, Giacomo Bianchi, Matteo Pettinari, Alessandro Barbone, José P. Garcia, Kiran Shekar, Glenn Whitman, Roberto Lorusso, PELS Investigators   +39 more
wiley   +1 more source

Occupational therapy predicts post-operative left ventricular assist device (LVAD) self-care, hospital length of stay, and discharge disposition. [PDF]

JHLT Open
Asiello JD, Cannone K, Lam N, Taubert A, Dittrich M, Gore S, Coglianese E, Kelley CM.   +7 more
europepmc   +1 more source

Pediatric Versus Adult Shear‐Induced Hemolysis—Are Age‐Related Blood Properties the Main Cause for Differences?

Artificial Organs, EarlyView.
Graphical summary of the experimental comparison of shear‐induced hemolysis in pediatric and adult blood using a Couette shearing device. Pediatric blood shows a trend toward lower increase in hemolysis at higher shear stress amplitudes, while no relevant differences are observed at low and intermediate stresses.
Vera Froese, Meike Fahrenholz, Ulrich Kertzscher, Michael Lommel, Maren Kleine‐Brueggeney   +4 more
wiley   +1 more source

Does Gastrointestinal Bleeding Increase the Risk of Thromboembolic Events in Patients Supported With CF‐LVADs?

Artificial Organs, EarlyView.
Gastrointestinal bleeding significantly increases thromboembolic risk. Higher risk was also seen in patients aged ≥ 50 years, Black patients, and those with older CF‐LVAD models. ABSTRACT Background Gastrointestinal bleeding is a common complication in continuous‐flow left ventricular assist device (CF‐LVAD) patients. Managing gastrointestinal bleeding
Anh Nguyen, Alexis Shafii, Gabriel Loor, Subhasis Chatterjee, Andrew Civitello, O. Howard Frazier, Kenneth Liao   +6 more
wiley   +1 more source

Patient-specific hemodynamic simulation for left ventricular assist device via non-invasive monitoring based on lumped parameter model and hierarchical neural network. [PDF]

Front Physiol
Lyu J, Liu X, Lin Z, Ji B, Gao Q, Shu Q, Fan X.   +6 more
europepmc   +1 more source